Publications by authors named "Michael Mross"

Claim this Profile
P
Prospective Evaluation of the Prediction Score for a Mild Course of Crohn's Disease (PreMiCC) in Newly Diagnosed Patients With Crohn's Disease: The PROGNOS Study.
Wolfgang Kruis, Bernd Bokemeyer, Petra Jessen, Mark Hoesl, Michael Mroß

Inflamm Bowel Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First epileptic seizure and quality of life - A prospective study.
Louise Linka, Selina Nephuth, Iris Gorny, Kristina Krause, Peter Michael Mross

Epilepsy Behav· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Iatrogenes Kaposi-Sarkom unter Vedolizumab bei Colitis ulcerosa].
Juliane Weilandt, Vincent Hoffmann, Axel Zahn, Silja Guski, Michael Mroß

J Dtsch Dermatol Ges· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn's disease patients: a German retrospective chart review.
Ulf Helwig, Michael Mross, Stefan Schubert, Heinz Hartmann, Alina Brandes

BMC Gastroenterol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency.
Bernd Bokemeyer, Annette Krummenerl, Christian Maaser, Stefanie Howaldt, Michael Mroß

Eur J Drug Metab Pharmacokinet· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of PICOPREP tailored dosing compared with PICOPREP day-before dosing for colon cleansing: a multi-centric randomised study.
Ralf Kiesslich, Stefan Schubert, Michael Mross, Tobias Klugmann, Michael Klemt-Kropp

Endosc Int Open· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data quality of the German screening colonoscopy registry.
Andreas Adler, David Lieberman, Alireza Aminalai, Jens Aschenbeck, Rolf Drossel

Endoscopy· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12,134 examinations (Berlin colonoscopy project 3, BECOP-3).
Andreas Adler, Karl Wegscheider, David Lieberman, Alireza Aminalai, Jens Aschenbeck

Gut· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol.
Xavier Hébuterne, Marc Lémann, Yoram Bouhnik, Olivier Dewit, Jean-Louis Dupas, Michael Mross

Gut· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
Axel U Dignass, Bernd Bokemeyer, Henning Adamek, Michael Mross, Lars Vinter-Jensen

Clin Gastroenterol Hepatol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis